Skip to main content

Find Clinical Trials

Home
Conditions
Retinoblastoma

Clinical trial condition

Retinoblastoma

Explore clinical trials studying Retinoblastoma. Study availability and eligibility vary by location and protocol.

78 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Retinoblastoma trial results

Completed

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

NCT00024258

Conditions: Adnexal Diseases, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +65 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

NCT01598454

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing's Sarcoma, Eye Diseases, +37 more
Locations: Prof. Dr. J. P. Garrahan National Children's Hospital Buenos Aires, Argentina

View Trial Details

Completed

CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma

NCT02319486

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +64 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

Miller Children's Hospital Long Beach, California, United States

View all 105 locations

View Trial Details

Completed

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

NCT00003597

Conditions: Adenocarcinoma, Agranulocytosis, Astrocytoma, +78 more
Locations: Long Beach Memorial Medical Center Long Beach, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Beckman Research Institute, City of Hope Los Angeles, California, United States

View all 24 locations

View Trial Details

Completed

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

NCT01048892

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +41 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 18 locations

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

NCT00003022

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +60 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

NCT00012181

Conditions: Astrocytoma, Burkitt Lymphoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +89 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Chemotherapy in Treating Patients With Retinoblastoma

NCT00002675

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

NCT00002515

Conditions: Adnexal Diseases, Burkitt Lymphoma, Childhood Germ Cell Tumor, +80 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details